AEMD - Aethlon Med Inc. - Page 28

From their website, the march issue is still the current one. There's no mention about when the next one is coming out.

hopefully money I can drop another $1k into this stock

me to hopefully (before it has a run)

Here's some news from a year ago, a good read if anyone hasn't seen it before.

Thursday, March 4, 2004

Aethlon Medical Announces National Center for Biodefense Agreement
Posted: 3/4/2004 @ 8:54 AM

Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has entered into a cooperative agreement with the National Center for Biodefense (NCBD) at George Mason University in Manassas, Virginia. Under the agreement, Aethlon and the NCBD will collaborate to develop pathogen and toxin filtration devices designed to protect the lives of U.S. military personnel exposed to infectious agents as a result of biological warfare.

"We look forward to working with Aethlon to advance the Hemopurifier(TM) treatment principle as an important new countermeasure against naturally occurring pathogens and biowarfare agents," stated Dr. Ken Alibek, executive director for education at the NCBD.

Aethlon and the NCBD will initially focus on advancing filtration devices that remove mediators produced in sepsis and septic shock, as well as treating "Category A" agents that are considered by the Centers for Disease Control (CDC) to be the worst bioterror threats. These agents include the viruses that cause Smallpox, hemorrhagic fevers such as Ebola and Marburg, the Anthrax bacteria, and Botulinum toxin. Each treatment device will be based on the same proprietary Hemopurifier(TM) filtration technology that is utilized in advancing Aethlon's HIV/AIDS, and Hepatitis-C treatments.

"Our colleagues at the NCBD are recognized globally for their expertise in combating biowarfare agents," stated James A. Joyce, Chairman and CEO of Aethlon Medical. "This relationship broadens our scientific resources and allows our organizations to jointly pursue business and funding opportunities within the federal government."

Does anyone know when they will start marketing this thing? That could be HUGE!!!!

Gus I sent a message to the company this past Wednesday asking the same question. Too date no response.

Harvey

Here's an item to listen to: An audio presentation of AEMD CEO from the Homeland Security Conference September 21, 2005. Remember to click on the slide numbers on the left when their number is mentioned by the presenter.


http://www.investorideas.com/forums/...iles/frame.htm

Well worth a listen.

Tried to read this on the company website and couldn't get it so in case other have had the same problem here's some news from Dec.05 . That enough DD for today, looking forward to a great week ahead.


Aethlon Medical Provides Progress Report to Wall Street

SAN DIEGO, Dec. 16, 2005 - Aethlon Medical, Inc., (OTCBB: AEMD):

Gives interim update of first human safety study of its Hemopurifier(TM)



Announces the CDC has initiated testing of Aethlon's technology as a potential treatment against the Ebola virus

Discusses the continued enhancement of its leadership team

Aethlon Medical, Inc., (OTCBB: AEMD) a pioneer in developing therapeutic devices for infectious disease, announced that its Chairman and CEO, James A. Joyce presented a company update yesterday at The New York Society of Security Analysts 9th Annual Biotech/Specialty Pharma Conference.

Aethlon's CEO provided the following updates:



Interim results of the company's first human safety study of its Hemopurifier(TM), which is designed to augment the immune response by clearing viruses and toxins from circulation, have shown no material adverse events in the first three patients treated. This is a small safety study of Hepatitis-C infected patients, in which patients were treated three times per week for four hours each day at the Apollo Hospital in New Delhi, India. The Apollo Hospital system is the largest in Asia, and forth largest in the world. Additional results will be provided upon completion of the study in the first quarter of 2006.



The company also announced that the Centers for Disease Control & Prevention (CDC), the U.S. agency at the forefront of public health efforts to prevent and control infectious diseases, has initiated early-stage testing of Aethlon's Hemopurifier(TM) as a potential treatment against the Ebola virus.



Aethlon also discussed the expansion of its leadership team as part of the transition from pure research and development to commercialization. In this regard, the company has attracted experienced talent to lead its finance and communications activities and has engaged formal representation in Washington, D.C. to help advance federal government and biodefense initiatives.



-- James Dorst, who joined Aethlon as Chief Financial

Officer, brings 20 years of senior management experience

in finance, operations, planning and business transactions

in both the public and private marketplaces. Prior to

joining Aethlon, Mr. Dorst was Vice President of Finance

and Operations for VerdiSoft Corporation, a

developmental-stage mobile-software developer recently

acquired by YAHOO, INC.



-- Jeffrey Richardson, has been appointed Senior Director,

Communications, has nearly 20 years of senior leadership

in international public relations for research-based

medical companies. Prior to joining Aethlon, Mr.

Richardson was Director, Global Public Relations for

Amgen, the world's largest biotechnology company.



-- Aethlon disclosed it has engaged McKenna Long & Aldridge

LLP to assist in obtaining government grants and

contracts. McKenna Long & Aldridge has an impressive track

record of producing results for clients in the emerging

biodefense industry.

good luck to everyone tommorrow!

.91 open WOW

Looking good so far.. volume isn't as high as last friday, but the current price is still on the rise.

they are going to really let this one go soon....they are trying to scare some people into selling. $2 range soon IMO

is this going to go any higher than .94. man this is a lazy stock

should pass $1 by EOD. Look for EOD run

i hope it keeps going, from the looks and releases they have done and that i have seen... we could see dollars

iam trying to sell it for .94 and no luck

Ended at .89... Still holding, I'm really confident in the stock. Large volume and a steady gain everyday.

$1.00+ soon, anyone have any other bird flu picks?

hm.. seems all the attention is going to STTK. Volume is pretty low for AEMD, but remaining steady at .92 so far.

April Issue Popular Science in Stores Now!!!

April issue of Popular Science Magazine is in Chapters bookstores now. According to AEMD press releases there's a two page article on the Hemopurifier. Just called Chapters and put an issue on hold. Going to pick it up now. Will post an image of the article ASAP.

Looking Good!